Supernus Pharmaceuticals(SUPN)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SUPN Supernus Pharmaceuticals

未开盘 05-07 16:00:00 EDT

31.15

+0.73

+2.40%

盘后31.15

+0.000.00%

16:44 EDT

最高31.31	最低30.41	成交量47.17万
今开30.56	昨收30.42	日振幅2.96%
总市值17.12亿	流通市值14.93亿	总股本5,497万
成交额1,464万	换手率0.98%	流通股本4,794万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SUPN","market":"US","secType":"STK","nameCN":"Supernus Pharmaceuticals","latestPrice":31.15,"timestamp":1715112000000,"preClose":30.42,"halted":0,"volume":471705,"hourTrading":{"tag":"盘后","latestPrice":31.15,"preClose":31.15,"latestTime":"16:44 EDT","volume":22109,"amount":688626.6428,"timestamp":1715114657182},"delay":0,"floatShares":47944919,"shares":54973754,"eps":0.02,"marketStatus":"未开盘","marketStatusCode":0,"change":0.73,"latestTime":"05-07 16:00:00 EDT","open":30.56,"high":31.31,"low":30.41,"amount":14640859.97985,"amplitude":0.029586,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.02,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715155200000},"adr":0,"listingDate":1335844800000,"adjPreClose":30.42,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":31.15,"preClose":31.15,"latestTime":"16:44 EDT","volume":22109,"amount":688626.6428,"timestamp":1715114657182},"volumeRatio":1.38762},"requestUrl":"/m/hq/s/SUPN","defaultTab":"news","newsList":[{"id":"2425224990","title":"嗡嗡声--美国股票走势-Ocugen、N 型、Fastly","url":"https://stock-news.laohu8.com/highlight/detail?id=2425224990","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2425224990?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:50","pubTimestamp":1712584215,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      4月8日 - 周一，由于对美国联邦储备委员会今年可能推迟降息的押注升温，国债收益率上升，追踪华尔街主要股指的期货市场基本表现平淡。美东时间9:23，道指电子盘  上涨0.13%，报39,274点。标准普尔500指数小型股  上涨0.22%，报5,264.75点；纳斯达克100指数小型股  上涨0.33%，报18,362点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414239243","title":"美国研究综述-Autozone、Constellation Energy、Sterling Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2414239243","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414239243?lang=zh_cn&edition=full","pubTime":"2024-02-28 15:20","pubTimestamp":1709104828,"startTime":"0","endTime":"0","summary":"    路透社2月28日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Autozone、Constellation Energy 和 Sterling Infrastructure。要闻             * Autozone Inc   ：杰富瑞将目标价从3100美元上调至3400美元             * Constellation Energy Corp   ：KeyBanc将目标价从行业权重上调至增持              * Sterling Infrastructure Inc   ：D.A.戴维森将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413742145","title":"Supernus Pharmaceuticals Inc   预计每股收益55美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413742145","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413742145?lang=zh_cn&edition=full","pubTime":"2024-02-24 10:16","pubTimestamp":1708740989,"startTime":"0","endTime":"0","summary":"   * Supernus Pharmaceuticals Inc    将于2月27日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马里兰州罗克维尔的公司的营收将从去年同期的1.6733亿美元下降7.3%，至1.55031亿美元。* LSEG 分析师对 Supernus Pharmaceuticals Inc 的平均预期为每股收益 55 美分。* 华尔街对 Supernus Pharmaceuticals Inc 的 12 个月目标价中位数为 41.50 美元，高于其最新收盘价 29.06 美元。2月24日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.supernus.com","stockEarnings":[{"period":"1week","weight":0.0349},{"period":"1month","weight":-0.0715},{"period":"3month","weight":0.1435},{"period":"6month","weight":0.1917},{"period":"1year","weight":-0.1533},{"period":"ytd","weight":0.0764}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Supernus Pharmaceuticals, Inc.于2005年3月30日在美国特拉华州注册成立，并于2005年12月22日开始运营。该公司是一家专业制药公司，专注于开发和商业化产品，为治疗中枢神经系统疾病，包括神经和精神治疗紊乱。公司有两个专利产品和几个专有候选产品的临床开发，可满足癫痫症和注意力缺陷多动障碍的市场需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.06073},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005563},{"month":3,"riseRate":0.5,"avgChangeRate":0.04471},{"month":4,"riseRate":0.666667,"avgChangeRate":0.029799},{"month":5,"riseRate":0.666667,"avgChangeRate":0.064138},{"month":6,"riseRate":0.75,"avgChangeRate":0.11448},{"month":7,"riseRate":0.583333,"avgChangeRate":0.020489},{"month":8,"riseRate":0.5,"avgChangeRate":-0.019853},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.022081},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.022339},{"month":11,"riseRate":0.583333,"avgChangeRate":0.001299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013553}],"exchange":"NASDAQ","name":"Supernus Pharmaceuticals","nameEN":"Supernus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Supernus Pharmaceuticals(SUPN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Supernus Pharmaceuticals(SUPN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Supernus Pharmaceuticals,SUPN,Supernus Pharmaceuticals股票,Supernus Pharmaceuticals股票老虎,Supernus Pharmaceuticals股票老虎国际,Supernus Pharmaceuticals行情,Supernus Pharmaceuticals股票行情,Supernus Pharmaceuticals股价,Supernus Pharmaceuticals股市,Supernus Pharmaceuticals股票价格,Supernus Pharmaceuticals股票交易,Supernus Pharmaceuticals股票购买,Supernus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Supernus Pharmaceuticals(SUPN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Supernus Pharmaceuticals(SUPN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况